These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20843368)

  • 21. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
    Liu W; Ip MM; Podgorsak MB; Das GM
    Breast Cancer Res Treat; 2009 May; 115(1):43-50. PubMed ID: 18481172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
    Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
    J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zac1 functional interactions mediate AP-1 transcriptional activity.
    Wang WM; Liu ST; Huang SM; Lin WS; Chen SG; Chang YL
    Biochim Biophys Acta; 2011 Dec; 1813(12):2050-60. PubMed ID: 21864583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
    Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
    Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antagonism between MCT-1 and p53 affects the tumorigenic outcomes.
    Kasiappan R; Shih HJ; Wu MH; Choy C; Lin TD; Chen L; Hsu HL
    Mol Cancer; 2010 Dec; 9():311. PubMed ID: 21138557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
    Racek T; Mise N; Li Z; Stoll A; Pützer BM
    J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1.
    Lopez MB; Garcia MN; Grasso D; Bintz J; Molejon MI; Velez G; Lomberk G; Neira JL; Urrutia R; Iovanna J
    J Cell Physiol; 2015 Dec; 230(12):2936-50. PubMed ID: 25899918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
    Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
    Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis.
    Yang PM; Huang WC; Lin YC; Huang WY; Wu HA; Chen WL; Chang YF; Chou CW; Tzeng CC; Chen YL; Chen CC
    J Cell Mol Med; 2010 Mar; 14(3):687-98. PubMed ID: 19243472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZBTB2, a novel master regulator of the p53 pathway.
    Jeon BN; Choi WI; Yu MY; Yoon AR; Kim MH; Yun CO; Hur MW
    J Biol Chem; 2009 Jul; 284(27):17935-46. PubMed ID: 19380588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.
    McPherson LA; Loktev AV; Weigel RJ
    J Biol Chem; 2002 Nov; 277(47):45028-33. PubMed ID: 12226108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.
    Naidu SR; Love IM; Imbalzano AN; Grossman SR; Androphy EJ
    Oncogene; 2009 Jul; 28(27):2492-501. PubMed ID: 19448667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA topoisomerase III alpha regulates p53-mediated tumor suppression.
    Hsieh MY; Fan JR; Chang HW; Chen HC; Shen TL; Teng SC; Yeh YH; Li TK
    Clin Cancer Res; 2014 Mar; 20(6):1489-501. PubMed ID: 24526736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy.
    Johansson EM; Kannius-Janson M; Bjursell G; Nilsson J
    Oncogene; 2003 Sep; 22(38):6061-70. PubMed ID: 12955085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.